Sort
82,697 grants matching “vaccine development”
Refinement of an autodissemination station for control of mosquito vectors
$722,493Michael Gilbert Banfield · Banfieldbio Inc. · R44 · FY2014 · AI
Adoptive T Lymphocyte Administration for Chronic Norovirus Treatment Following Hematopoietic Stem Cell Transplantation
$722,458Michael Daniel Keller · Children'S Research Institute · R01 · FY2021 · HL
Modulation Of Protein And Cell Functions By Heparin/heparan Sulfate And Mimetics
$722,455Audrey L Stone · Child Health And Human Development · Z01 · FY2007 · HD
Human monoclonal panel mimicking anthrax immune globulin
$722,405Children'S Hospital &Res Ctr At Oakland · R01 · FY2005 · AI
SIV Transmission in Male NHP
$722,403Christopher Miller · University Of California At Davis · R01 · FY2012 · AI
Rejuvenation of the T-cell compartment in aging primates
$722,375Louis J. Picker · Oregon Health & Science University · R01 · FY2009 · AI
Clinical Trials and Ancillary Assays
$722,307Harriet L Robinson · Geovax, Inc. · U19 · FY2009 · AI
Identification and characterization of effector memory B cell populations that dominate memory responses to subsequent influenza infection and vaccination
$722,300Frances E. Lund · University Of Alabama At Birmingham · R01 · FY2020 · AI
Development of pan-betacoronavirus vaccines
$722,284Raiees Ahmad Andrabi · University Of Pennsylvania · R01 · FY2024 · AI
The tale of two pandemics: Understanding racial and ethnic disparities from the collision of HIV and COVID-19 in the U.S.
$722,272Rena Chiman Patel · University Of Washington · R01 · FY2022 · MH
Development of a novel quadrivalent seasonal influenza vaccine using E.coli production technology
$722,269Shengqiang Li · Sciogen, Llc · R44 · FY2017 · AI
VARICELLA ZOSTER VIRUS PATHOGENESIS
$722,210State University Of New York At Buffalo · R01 · FY2000 · AI
Task A45: Cotton Rat Model for the Evaluation of Vaccines and Therapeutics for RSV and Related Viruses
$722,205Steve Hauschild · Sigmovir Biosystems, Inc. · N01 · FY2022 · AI
Development of lung T cell responses in infant respiratory immunity
$722,112Donna L Farber · Columbia University Health Sciences · R01 · FY2015 · AI
Structural Vaccinology and Design of Novel Imunogens for Malaria Vaccine Development
$722,058Daniel E Goldberg · Washington University · R01 · FY2020 · AI
CNS Senescence and Immunopathology in Lethal POWV Infection of Aged Mice
$722,026Erich R. Mackow · State University New York Stony Brook · R01 · FY2024 · AI
CNS Senescence and Immunopathology in Lethal POWV Infection of Aged Mice
$722,026Erich R. Mackow · State University New York Stony Brook · R01 · FY2025 · AI
Development of an RSV vaccine for the elderly
$721,972Trudy G. Morrison · Univ Of Massachusetts Med Sch Worcester · R01 · FY2021 · AI
Development of an RSV vaccine for the elderly
$721,972Trudy G. Morrison · Univ Of Massachusetts Med Sch Worcester · R01 · FY2022 · AI
Development of an RSV vaccine for the elderly
$721,972Trudy G. Morrison · Univ Of Massachusetts Med Sch Worcester · R01 · FY2023 · AI
Development of an RSV vaccine for the elderly
$721,972Trudy G. Morrison · Univ Of Massachusetts Med Sch Worcester · R01 · FY2024 · AI
Career Development and Training Program
$721,955David H Walker · University Of Texas Med Br Galveston · U54 · FY2009 · AI
Novel Nanovaccines Against Nicotine Addiction
$721,919Chenming M Zhang · Virginia Polytechnic Inst And St Univ · U01 · FY2016 · DA
Development of a Replicon RNA-based Vaccine against Dengue and Zika
$721,849Sujan Shresta · La Jolla Institute For Immunology · R01 · FY2023 · AI
Development of a Replicon RNA-based Vaccine against Dengue and Zika
$721,849Sujan Shresta · La Jolla Institute For Immunology · R01 · FY2025 · AI